Influence of genetic and environmental factors on the immunogenicity of Hib vaccine in Gambian twins

Vaccine

Volumn 24, Issue 25, 2006, Pages 5335-5340

  Lee, Y C ^a   Newport, M J ^b,c   Goetghebuer, T ^b,d   Siegrist, C A ^e   Weiss, H A ^f   Pollard, A J ^a   Marchant, A ^b,g  

^a UNIVERSITY OF OXFORD   (United Kingdom)

^b MEDICAL RESEARCH COUNCIL LABORATORIES   (Gambia)

^c BRIGHTON AND SUSSEX MEDICAL SCHOOL   (United Kingdom)

^d SAINT PIERRE UNIVERSITY HOSPITAL   (Belgium)

^e UNIVERSITY OF GENEVA   (Switzerland)

^f LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE   (United Kingdom)

^g UNIVERSITÉ LIBRE DE BRUXELLES   (Belgium)

Author keywords

Antibody; Genetic predisposition; Haemophilus influenzae vaccine

Indexed keywords

BCG VACCINE; DIPHTHERIA PERTUSSIS TETANUS VACCINE; HAEMOPHILUS INFLUENZAE TYPE B VACCINE; HEPATITIS B VACCINE; POLIOMYELITIS VACCINE;

ANTIBODY BLOOD LEVEL; ANTIBODY RESPONSE; ARTICLE; CONFIDENCE INTERVAL; CORRELATION ANALYSIS; DIZYGOTIC TWINS; ECOLOGICAL GENETICS; ENVIRONMENTAL FACTOR; ENZYME LINKED IMMUNOSORBENT ASSAY; ETHNOLOGY; FEMALE; GENETIC VARIABILITY; GENETICS; HAEMOPHILUS INFLUENZAE TYPE B; HERITABILITY; HUMAN; IMMUNE RESPONSE; IMMUNOGENICITY; INCIDENCE; INFLUENZA; MALE; MEASUREMENT; MONOZYGOTIC TWINS; NEWBORN; NORMAL HUMAN; PHARMACOGENOMICS; POPULATION GENETICS; PRIORITY JOURNAL; VACCINE FAILURE;

ANTIBODIES, BACTERIAL; DIPHTHERIA-TETANUS-PERTUSSIS VACCINE; DISEASES IN TWINS; FEMALE; GAMBIA; HAEMOPHILUS INFECTIONS; HAEMOPHILUS INFLUENZAE; HAEMOPHILUS VACCINES; HUMANS; IMMUNIZATION SCHEDULE; INFANT; INFANT, NEWBORN; INFANT, PREMATURE; MALE; TWINS; TWINS, DIZYGOTIC; TWINS, MONOZYGOTIC; VACCINES, CONJUGATE;

EID: 33744517008     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vaccine.2006.04.021     Document Type: Article

References (38)

1. Watt J.P., Levine O.S., and Santosham M. Global reduction of Hib disease: what are the next steps?. Proceedings of the meeting Scottsdale, Arizona. September 22-25, 2002. J Pediatr 143 Suppl. 6 (2003) S163-S187
2. Siber G.R., Santosham M., Reid G.R., Thompson C., Almeido-Hill J., Morell A., et al. Impaired antibody response to Haemophilus influenzae type b polysaccharide and low IgG2 and IgG4 concentrations in Apache children. N Engl J Med 323 20 (1990) 1387-1392
3. Heath P.T. Haemophilus influenzae type b conjugate vaccines: a review of efficacy data. Pediatr Infect Dis J 17 Suppl. 9 (1998) S117-S122
4. Hetherington S.V., and Lepow M.L. Correlation between antibody affinity and serum bactericidal activity in infants. J Infect Dis 165 4 (1992) 753-756
5. Galil K., Singleton R., Levine O.S., Fitzgerald M.A., Bulkow L., Getty M., et al. Reemergence of invasive Haemophilus influenzae type b disease in a well-vaccinated population in remote Alaska. J Infect Dis 179 1 (1999) 101-106
6. Mohle-Boetani J.C., Ajello G., Breneman E., Deaver K.A., Harvey C., Plikaytis B.D., et al. Carriage of Haemophilus influenzae type b in children after widespread vaccination with conjugate Haemophilus influenzae type b vaccines. Pediatr Infect Dis J 12 7 (1993) 589-593
7. Murphy T.V., Pastor P., Medley F., Osterholm M.T., and Granoff D.M. Decreased Haemophilus colonization in children vaccinated with Haemophilus influenzae type b conjugate vaccine. J Pediatr 122 4 (1993) 517-523
8. Takala A.K., Eskola J., Leinonen M., Kayhty H., Nissinen A., Pekkanen E., et al. Reduction of oropharyngeal carriage of Haemophilus influenzae type b (Hib) in children immunized with an Hib conjugate vaccine. J Infect Dis 164 5 (1991) 982-986
9. Barbour M.L., Mayon-White R.T., Coles C., Crook D.W., and Moxon E.R. The impact of conjugate vaccine on carriage of Haemophilus influenzae type b. J Infect Dis 171 1 (1995) 93-98
10. Adegbola R.A., Mulholland E.K., Secka O., Jaffar S., and Greenwood B.M. Vaccination with a Haemophilus influenzae type b conjugate vaccine reduces oropharyngeal carriage of H. influenzae type b among Gambian children. J Infect Dis 177 6 (1998) 1758-1761
11. Forleo-Neto E., de Oliveira C.F., Maluf E.M., Bataglin C., Araujo J.M., Kunz Jr. L.F., et al. Decreased point prevalence of Haemophilus influenzae type b (Hib) oropharyngeal colonization by mass immunization of Brazilian children less than 5 years old with Hib polyribosylribitol phosphate polysaccharide-tetanus toxoid conjugate vaccine in combination with diphtheria-tetanus toxoids-pertussis vaccine. J Infect Dis 180 4 (1999) 1153-1158
12. Hargreaves R.M., Slack M.P., Howard A.J., Anderson E., and Ramsay M.E. Changing patterns of invasive Haemophilus influenzae disease in England and Wales after introduction of the Hib vaccination programme. BMJ 312 7024 (1996) 160-161
13. Parke Jr. J.C., Schneerson R., and Robbins J.B. The attack rate, age incidence, racial distribution, and case fatality rate of Haemophilus influenzae type b meningitis in Mecklenbury County, North Carolina. J Pediatr 81 4 (1972) 765-769
14. Lolekha S., Cooksley G., Chan V., Isahak I., Ismael S., John J., et al. A review of Hib epidemiology in Asia. Southeast Asian J Trop Med Public Health 31 4 (2000) 650-657
15. Granoff D.M., Squires J.E., Munson Jr. R.S., and Suarez B. Siblings of patients with Haemophilus meningitis have impaired anticapsular antibody responses to Haemophilus vaccine. J Pediatr 103 2 (1983) 185-191
16. Ambrosino D.M., Schiffman G., Gotschlich E.C., Schur P.H., Rosenberg G.A., DeLange G.G., et al. Correlation between G2m (n) immunoglobulin allotype and human antibody response and susceptibility to polysaccharide encapsulated bacteria. J Clin Invest 75 6 (1985) 1935-1942
17. Granoff D.M., Suarez B.K., Pandey J.P., and Shackelford P.G. Genes associated with the G2m (23) immunoglobulin allotype regulate the IgG subclass responses to Haemophilus influenzae type b polysaccharide vaccine. J Infect Dis 157 6 (1988) 1142-1149
18. Newport M.J., Goetghebuer T., Weiss H.A., Whittle H., Siegrist C.A., and Marchant A. Genetic regulation of immune responses to vaccines in early life. Genes Immun 5 2 (2004) 122-129
19. Phipps D.C., West J., Eby R., Koster M., Madore D.V., and Quataert S.A. An ELISA employing a Haemophilus influenzae type b oligosaccharide-human serum albumin conjugate correlates with the radioantigen binding assay. J Immunol Methods 135 1/2 (1990) 121-128
20. Becker A., Busjahn A., Faulhaber H.D., Bahring S., Robertson J., Schuster H., et al. Twin zygosity. Automated determination with microsatellites. J Reprod Med 42 5 (1997) 260-266
21. Neale M.C., and Miller M.B. The use of likelihood-based confidence intervals in genetic models. Behav Genet 27 2 (1997) 113-120
22. Bell F., Martin A., Blondeau C., Thornton C., Chaplais J., and Finn A. Combined diphtheria, tetanus, pertussis, and Haemophilus influenzae type b vaccines for primary immunization. Arch Dis Child 75 4 (1996) 298-303
23. Dagan R., Eskola J., Leclerc C., and Leroy O. Reduced response to multiple vaccines sharing common protein epitopes that are administered simultaneously to infants. Infect Immun 66 5 (1998) 2093-2098
24. Finn A., Blondeau C., and Bell F. Haemophilus influenzae type B (Hib) antibody responses in children given diphtheria-tetanus-acellular pertussis-Hib combination vaccines. J Infect Dis 181 6 (2000) 2117-2118
25. Goldblatt D., Richmond P., Millard E., Thornton C., and Miller E. The induction of immunologic memory after vaccination with Haemophilus influenzae type b conjugate and acellular pertussis-containing diphtheria, tetanus, and pertussis vaccine combination. J Infect Dis 180 2 (1999) 538-541
26. Bernasconi N.L., Traggiai E., and Lanzavecchia A. Maintenance of serological memory by polyclonal activation of human memory B cells. Science 298 5601 (2002) 2199-2202
27. Bisgard K.M., Kao A., Leake J., Strebel P.M., Perkins B.A., and Wharton M. Haemophilus influenzae invasive disease in the United States, 1994-1995: near disappearance of a vaccine-preventable childhood disease. Emerg Infect Dis 4 2 (1998) 229-237
28. Heath P.T., and McVernon J. The UK Hib vaccine experience. Arch Dis Child 86 6 (2002) 396-399
29. Ramsay M.E., McVernon J., Andrews N.J., Heath P.T., and Slack M.P. Estimating Haemophilus influenzae type b vaccine effectiveness in England and Wales by use of the screening method. J Infect Dis 188 4 (2003) 481-485
30. Heath P.T., Booy R., Azzopardi H.J., Slack M.P., Bowen-Morris J., Griffiths H., et al. Antibody concentration and clinical protection after Hib conjugate vaccination in the United Kingdom. JAMA 284 18 (2000) 2334-2340
31. Kelly D.F., Moxon E.R., and Pollard A.J. Haemophilus influenzae type b conjugate vaccines. Immunology 113 2 (2004) 163-174
32. Goldblatt D., Johnson M., and Evans J. Antibody responses to Haemophilus influenzae type b conjugate vaccine in sickle cell disease. Arch Dis Child 75 2 (1996) 159-161
33. Webber S.A., Sandor G.G., Patterson M.W., Mitchell L.A., Scheifele D., Ochnio J.J., et al. Immunogenicity of Haemophilus influenzae type b conjugate vaccine in children with congenital asplenia. J Infect Dis 167 5 (1993) 1210-1212
34. Guinan E.C., Molrine D.C., Antin J.H., Lee M.C., Weinstein H.J., Sallan S.E., et al. Polysaccharide conjugate vaccine responses in bone marrow transplant patients. Transplantation 57 5 (1994) 677-684
35. McVernon J., Andrews N., Slack M.P., and Ramsay M.E. Risk of vaccine failure after Haemophilus influenzae type b (Hib) combination vaccines with acellular pertussis. Lancet 361 9368 (2003) 1521-1523
36. McVernon J., Mitchison N.A., and Moxon E.R. T helper cells and efficacy of Haemophilus influenzae type b conjugate vaccination. Lancet Infect Dis 4 1 (2004) 40-43
37. McVernon J., Johnson P.D., Pollard A.J., Slack M.P., and Moxon E.R. Immunologic memory in Haemophilus influenzae type b conjugate vaccine failure. Arch Dis Child 88 5 (2003) 379-383
38. Heath P.T., Booy R., Griffiths H., Clutterbuck E., Azzopardi H.J., Slack M.P., et al. Clinical and immunological risk factors associated with Haemophilus influenzae type b conjugate vaccine failure in childhood. Clin Infect Dis 31 4 (2000) 973-980